Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

13.98 USD -0.56 (-3.85%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 Next >
Why BioCryst Pharmaceuticals Stock Is Skyrocketing This Week
Investors loved the drugmaker's update earlier this week. 
Tags Recent Press Releases BCRX Market News
From Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, Here's How Much You Would Have Today
BioCryst Pharmaceuticals (NASDAQ:BCRX) has outperformed the market over the past 10 years by 5.6% on an annualized basis. Buying ... 
Tags Benzinga News Market News
From Benzinga
BioCryst Is On Fire: What Do Options Traders Expect Next?
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) surged 11.16% to close Tuesday’s trading at $16.43, after the company ... 
Tags Long Ideas Optimize Advisors Media
From Benzinga
60 Biggest Movers From Yesterday
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) ... 
Tags RKDA HOUR PSTI
From Benzinga
Notable Monday Option Activity: CNXC, BYND, BCRX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Concentrix Corp (CNXC), where a total of 2,269 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Why BioCryst Pharmaceuticals Stock Is Jumping on Monday
Investors are cheering for preliminary fourth-quarter Orladeyo sales and guidance for 2022. 
Tags Recent Press Releases BCRX Market News
From Motley Fool
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
The bloodbath continued for biotech stocks Monday despite massive deals for Pfizer and Bayer in gene-editing technology. 
From Investor's Business Daily
45 Stocks Moving In Monday's Mid-Day Session
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to ... 
Tags Benzinga FOLD DISCB
From Benzinga
The Math Shows TUSA Can Go To $57
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Notable Friday Option Activity: TTCF, BCRX, SAVA
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tattooed Chef Inc (TTCF), where a total volume of 9,124 contracts has been traded... 
Tags Stocks
From Market News Video
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:ARNC) was changed from Neutral to Overweight. ... 
Tags PNC SPRB ARNC
From Benzinga
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
These eight stocks could rebound nicely over the next year and beyond. 
Tags AFMD Market News AUPH
From Motley Fool
Peek Under The Hood: FAD Has 17% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BCRX Trading Below Director's Recent Buy Price
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 24, BioCryst Pharmaceuticals Inc's Director,... 
Tags Stocks
From Market News Video
2 Ultra-High-Yield Dividend Stocks to Buy as a Hedge Against Inflation
Icahn Enterprises and Takeda Pharmaceutical are two intriguing hedges against sky-high inflation rates. 
Tags Recent Press Releases BCRX Market News
From Motley Fool
3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich. 
Tags BNGO BCRX Recent Press Releases
From Motley Fool
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. ... 
Tags Markets Trading Ideas Market News
From Benzinga
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
Royalty Pharma plc(NASDAQ: RPRX) andOMERS Capital Marketshave announced transactions worth$350 million in new ... 
Tags Biotech Health Care Benzinga
From Benzinga
7 Top Growth Stocks to Buy as We Step Into November
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here are seven top growth stocks investors may want to consider when looking at options in this hyper-growth market right now. The post 7... 
Tags BCRX SQ Market News
From InvestorPlace
Stock Upgrades: Biocryst Pharmaceuticals Shows Rising Relative Strength
Biocryst Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire ... 
Tags Top Gainers FGF Information Technology
From Benzinga
Noteworthy Wednesday Option Activity: OTRK, DKS, BCRX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ontrak Inc (OTRK), where a total of 6,061 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript
BCRX earnings call for the period ending September 30, 2021. 
Tags BCRX Market News
From Motley Fool
BCRX Makes Notable Cross Below Critical Moving Average
In trading on Wednesday, shares of BioCryst Pharmaceuticals Inc (BCRX) crossed below their 200 day moving average of $13.72, changing hands as low as $12.75 per share. BioCryst Pharmaceuticals Inc... 
Tags Stocks
From Market News Video
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
The biotech's third quarter was a good one, once you look past the top-line numbers. 
Tags BCRX Market News TAK
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular ... 
Tags BCRX BBLG GKOS
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market ... 
Tags Benzinga Top Gainers Pre/Market Outlook
From Benzinga
The Math Shows FYC Can Go To $85
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of June 2022 Options Trading For BioCryst Pharmaceuticals (BCRX)
Investors in BioCryst Pharmaceuticals Inc (BCRX) saw new options begin trading this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tenet Healthcare (NYSE:THC) stock rose 7.06% to $70.3 during Wednesday's after-market session. Today's trading volume for ... 
Tags GBS BZI/TFM OTRKP
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.